MAPK8IP2 and carcinoma: For the validation of some key genes identified in adenoma (IL6ST, GLI3) and carcinoma (MAPK8IP2, CPEB4) patients, survival analysis was completed by using the Kaplan–Meier Plotter (Figure 12A–C).